Creatine monohydrate has more peer-reviewed studies supporting its safety and efficacy than any other supplement in sports nutrition — over 500 published studies across 30 years of research, consensus position statements from the International Society of Sports Nutrition (ISSN), the American College of Sports Medicine, and the British Dietetic Association, and a safety profile established across both short-term high-dose loading studies and multi-year continuous supplementation trials. It is not a performance-enhancing drug. It is not dangerous. It is not "just for bodybuilders." It is a naturally occurring compound found in meat and fish, synthesized in the human body, stored primarily in skeletal muscle as phosphocreatine, and supplemented to increase muscle phosphocreatine stores beyond what diet and endogenous synthesis can achieve.
The mechanism is elementary: high-intensity exercise depletes ATP (adenosine triphosphate — the universal cellular energy currency) faster than aerobic metabolism can regenerate it. Phosphocreatine donates a phosphate group to ADP to regenerate ATP nearly instantaneously — this is the phosphocreatine system, which powers the first 10–30 seconds of maximal effort. More phosphocreatine in muscle = more ATP available for those critical early seconds = more reps, more sprint repeats, more power output. The downstream effect: greater training volume accumulates over weeks, leading to greater strength and hypertrophy adaptations. What is less commonly appreciated is that the brain also stores and uses phosphocreatine, and creatine supplementation influences cognitive performance — particularly in states of depletion (sleep deprivation, mental fatigue, vegetarian/vegan diets that provide minimal dietary creatine).
| Form | Bioavailability | Cost | Evidence Base | Verdict |
|---|---|---|---|---|
| Creatine monohydrate | ~99% absorbed; muscle saturation equivalent to all other forms | Cheapest ($0.05–0.15/5g) | 500+ studies; ISSN gold standard | Best choice for virtually everyone |
| Micronized creatine monohydrate | Same as monohydrate; smaller particle size improves dissolution in water | Slightly more expensive | Same as monohydrate; just different particle size | Good if you prefer easier mixing; no performance difference |
| Creatine HCL | Higher solubility but NOT higher muscle uptake vs monohydrate at equivalent doses | 3–5× more expensive | Much less research; marketed heavily by supplement companies | No advantage over monohydrate; price premium is marketing |
| Creatine ethyl ester (CEE) | Lower; partially converted to creatinine (inactive metabolite) before absorption | More expensive | Katseres 2009: CEE inferior to monohydrate for muscle creatine uptake | Worse than monohydrate; avoid |
| Buffered creatine (Kre-Alkalyn) | Claims to be "more stable"; no evidence of superior uptake | Much more expensive | Jagim 2012: Kre-Alkalyn not superior to monohydrate in muscle uptake or performance | No advantage; marketing claim |
| Creatine nitrate | Similar to monohydrate; may have minor additive nitric oxide effects | More expensive | Limited research; no proven advantage over monohydrate | No established advantage; insufficient evidence |
Which product to buy: Creapure (AlzChem, Germany) is the most widely third-party tested creatine monohydrate and the ingredient used in most clinical trials; any product labeled "Creapure" meets pharmaceutical-grade purity standards; micronized creatine monohydrate (without the Creapure label) from reputable brands (Thorne, NOW Sports, Bulk Supplements) is also fine; avoid proprietary blends that mask creatine content; look for NSF Certified for Sport or Informed Sport certifications if you are a drug-tested athlete.
Standard protocol (no loading): 5g creatine monohydrate daily; timing does not significantly affect muscle saturation outcomes — take it whenever is convenient and most likely to be consistent; post-workout with a meal slightly improves uptake vs fasted (insulin facilitates creatine transport into muscle cells — a modest effect, not critical); mix with water, juice, or protein shake; dissolve fully (warm water helps monohydrate dissolve).
Loading protocol (optional): 20g/day divided into 4 × 5g doses × 5–7 days, then 3–5g/day maintenance; reduces time to full muscle saturation from 28 days to 5–7 days; recommended if you have a competition or performance event within 2–3 weeks and want full saturation sooner; GI discomfort (bloating, loose stools) from 5g doses is manageable; taking with food reduces GI issues.
Older adults and sarcopenia: creatine is particularly valuable for adults over 50; Candow 2014 (J Nutr Health Aging, meta-analysis): creatine supplementation during resistance training in adults over 55 produced greater lean mass gains (+1.37 kg) and strength improvements vs resistance training alone; combined with adequate protein (1.6–2.2g/kg/day) and resistance training, creatine is one of the most evidence-backed interventions for preserving muscle mass and function in aging; no dose reduction needed for older adults — 5g/day is the studied and effective dose.
Creatine for cognition — specific protocol: for cognitive effects (particularly relevant in sleep deprivation, aging, vegetarians): 5g/day is sufficient for muscle phosphocreatine; some cognitive studies used higher doses (10g/day); if cognitive benefit is a primary goal (not muscle performance), 5–10g/day with consistent daily dosing is appropriate; effects take 4–6 weeks of supplementation to manifest as brain phosphocreatine increases are slower and smaller than muscle increases.
Does creatine need to be cycled? No. There is no evidence that cycling creatine on and off is beneficial or necessary; continuous daily supplementation is safe and maintains elevated muscle phosphocreatine; stopping creatine causes muscle phosphocreatine to return to baseline over 4–6 weeks — you lose the performance benefit but there is no rebound or withdrawal effect.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.